Based on the company's industry expertise in innovative pharmaceuticals and medical technology, the new Johnson & Johnson will be committed to promoting the prevention, diagnosis, treatment and cure of complex diseases, and bringing smarter, less invasive and more personalized medical solutions. In the future, the two major businesses of Johnson & Johnson will be more closely linked under the Johnson & Johnson brand. The company's pharmaceutical business Janssen will be renamed Johnson & Johnson Innovative Medicine, while Johnson & Johnson MedTech will remain unchanged.
